Human MMP9 Protein Vector: E.coli
- Known as:
- Human MMP9 Protein Vector: E.coli
- Catalog number:
- 10264-H01H
- Product Quantity:
- 50μg
- Category:
- -
- Supplier:
- Provo
- Gene target:
- Human MMP9 Protein Vector: .coli
Related genes to: Human MMP9 Protein Vector: E.coli
- Gene:
- FCN2 NIH gene
- Name:
- ficolin 2
- Previous symbol:
- -
- Synonyms:
- P35, FCNL, EBP-37, ficolin-2
- Chromosome:
- 9q34.3
- Locus Type:
- gene with protein product
- Date approved:
- 1996-07-11
- Date modifiied:
- 2016-10-05
- Gene:
- MMP9 NIH gene
- Name:
- matrix metallopeptidase 9
- Previous symbol:
- CLG4B
- Synonyms:
- -
- Chromosome:
- 20q13.12
- Locus Type:
- gene with protein product
- Date approved:
- 1990-03-14
- Date modifiied:
- 2015-02-23
Related products to: Human MMP9 Protein Vector: E.coli
Related articles to: Human MMP9 Protein Vector: E.coli
- Endometrial polyps (EP) can lead to irregular bleeding and infertility in women. The identification of biomarkers associated with EP holds clinical importance. - Source: PubMed
Publication date: 2026/10/02
Xu XiaoyanYang JianmeiHu QianqianZhao LiZhang YufengYan Yuxuan - To explore the correlation of serum brain-derived neurotrophic factor (BDNF), matrix metalloproteinase-9 (MMP-9), and glutamate (Glu) changes with functional recovery after repetitive transcranial magnetic stimulation (rTMS) in acute ischemic stroke (AIS) patients, so as to provide biological evidence for rTMS efficacy evaluation. - Source: PubMed
Publication date: 2026/09/17
Li XiaohuiSui YiHan XinruGuo HuiminWei MingyangLiu Fengjie - Distant metastasis and chemoresistance render the prognosis of follicular thyroid cancer (FTC) unsatisfactory. Acacetin, which is found in various traditional Chinese medicinal herbs, has been reported to exert antitumor effects. Herein, the molecular mechanisms of acacetin on the proliferation of FTC WRO cells were demonstrated. - Source: PubMed
Lee Sheng-TaChen Pei-NiChen Ke-MinWu Ying-ChinHsieh Yu-RueiLi Yu-ChiTsao DER-AnHsu Li-Sung - Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that is mediated by pro-inflammatory cytokines, like interleukin-6 (IL-6). IL-6 plays an important role in synovial inflammation and joint degradation. In this study, a combined in silico, in vitro and in vivo approach was used to identify and preliminarily evaluate valganciclovir hydrochloride as potential modulator of IL-6 receptor mediated inflammatory signalling. Docking studies showed that valganciclovir hydrochloride had favourable binding affinity with IL-6 receptor, and interacted stably with active site. ADMET analysis showed that compound possessed desirable ADMET properties, with good absorption and distribution, and low toxicity. Molecular binding free energy indicated stability of the protein-ligand complex. Moreover, 100 ns molecular dynamics simulation showed stable RMSD, with consistent key interactions, suggesting a dynamically stable protein-ligand complex in the physiological environment. Binding assay further demonstrated concentration dependent inhibition of IL-6:IL-6R interaction. Furthermore, in vivo assessment in collagen induced arthritis rats showed that treatment with valganciclovir hydrochloride resulted in marked reduction in disease severity. The treatment groups demonstrated a decrease in paw swelling, ESR, CRP, RF and IL-6 expression. Treatment also reduced downstream inflammatory mediators such as IL-17, MMP-9, p-STAT3, STAT3 and JAK2, suggesting attenuation of IL-6 associated inflammatory signalling In addition, antioxidant enzyme levels were restored with reduction in lipid peroxidation. The results indicate that valganciclovir hydrochloride has favourable binding interactions, and pharmacokinetics, as well as strong anti-inflammatory and anti-arthritic potential. The combined computational and experimental results support the possible involvement of IL-6/JAK2/STAT3 associated signalling pathways in observed anti-arthritic effects of valganciclovir hydrochloride. - Source: PubMed
Publication date: 2026/10/01
Jain DhawalGupta AnugyaAgarwal VipulSingh Bhuvnesh KumarChaudhary AmitKumar Pranesh - A pH-responsive CEC/PEG-(CHO) hydrogel scaffold was engineered for local delivery of neuropeptide S (NPS) to modulate the hostile microenvironment after spinal cord injury (SCI). The scaffold exhibited accelerated degradation under acidic conditions mimicking the injured site, enabling controlled release of NPS. Its porous microstructure (50-150 μm pore size) and compressive elastic modulus (0.081 MPa, slightly softer than that of a native spinal cord) provide a mechanical microenvironment conducive to neuronal survival and differentiation. In a T11 complete transection mouse model, the NPS-loaded scaffold significantly attenuated local inflammation (reduced MMP-9, TNF-α, CD68; increased IL-10), suppressed glial scar formation, recruited endogenous Nestin neural stem/progenitor cells (NSPCs), and promoted their differentiation into mature MAP2 neurons with enhanced myelination (MBP) and synaptic integration (SYP/MAP2). These effects were mediated through the NPS-NPSR axis and downstream Ca/cAMP signaling pathways. This study demonstrates that a rationally designed pH-responsive hydrogel can effectively remodel the SCI microenvironment and activate endogenous neural repair mechanisms, offering a promising strategy for SCI treatment. - Source: PubMed
Publication date: 2026/09/16
Xu BaiCheng MengdanGao YanWu YiqingXu RanShi WentaoZhao PengLu Xiaojie